{
    "2019-09-03": [
        [
            {
                "time": "",
                "original_text": "继 续 看 好 医 药 核 心 资 产 ， 坚 守 创 新 、 消 费 和 器 械 【 西 南 医 药 | 0901 周 报 】",
                "features": {
                    "keywords": [
                        "医药",
                        "核心资产",
                        "创新",
                        "消费",
                        "器械"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "渝 股 看 台 ｜ 国 城 矿 业 4 . 4 亿 元 回 购 3 8 9 6 万 股 ， 智 飞 生 物 一 疫 苗 获 批 临 床 试 验",
                "features": {
                    "keywords": [
                        "国城矿业",
                        "回购",
                        "智飞生物",
                        "疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "矿业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智 飞 生 物 : 业 绩 持 续 高 增 长 , H P V 疫 苗 空 间 广 阔",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩增长",
                        "HPV疫苗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}